MicroRNA therapy inhibits hepatoblastoma growth in vivo by targeting β-catenin and Wnt signaling.
Indersie E, Lesjean S, Hooks KB, Sagliocco F, Ernault T, Cairo S, Merched-Sauvage M, Rullier A, Le Bail B, Taque S, Grotzer M, Branchereau S, Guettier C, Fabre M, Brugières L, Hagedorn M, Buendia MA, Grosset CF.
Indersie E, et al. Among authors: sagliocco f.
Hepatol Commun. 2017 Apr 6;1(2):168-183. doi: 10.1002/hep4.1029. eCollection 2017 Apr.
Hepatol Commun. 2017.
PMID: 29404451
Free PMC article.